Eva Teufel

<i>CIC</i> Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement

Matteo Da Vià, Antonio Giovanni Solimando, Andoni Garitano-Trojaola et al. · The Oncologist · 2019 · 59 citations · Full text

Medicine, Hematology, Oncology +17

Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia

Andoni Garitano-Trojaola, Ana Sancho, Ralph Götz et al. · Communications Biology · 2021 · 29 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the β2 and β1 subunits of the proteasome complex

Xiang Zhou, Andrej Bešše, Jessica Peter et al. · Haematologica · 2023 · 11 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17